Putnam Associates is a premier strategy consulting firm serving biopharmaceutical, diagnostics, and medical device clients, and the private equity / venture capital community. For 30 years, we have offered objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle.
In 2019, Putnam formed a select panel of cell and gene therapy (CGT) experts to meet our clients’ growing demand for CGT strategy and commercialization support. By engaging with our expert panel, Putnam is at the leading edge of this rapidly evolving space, delivering to our CGT-focused clients unparalleled insight into clinical decision-making, product on-boardingread more
November 23, 2020 Boston, MA Putnam Associates has been named one of the Top Places to Work in Massachusetts in the 13th annual employee-based survey project from The Boston Globe. The Top Places to Work 2020 issue publishes online at Globe.com/TopPlaces on the night of November 19 and in Globe Magazine on November 22. Top Placesread more
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.